Viewing Study NCT04630158


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2025-12-25 @ 10:03 PM
Study NCT ID: NCT04630158
Status: COMPLETED
Last Update Posted: 2024-10-09
First Post: 2020-11-12
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-04-21
Start Date Type: ACTUAL
Primary Completion Date: 2023-06-07
Primary Completion Date Type: ACTUAL
Completion Date: 2023-06-08
Completion Date Type: ACTUAL
First Submit Date: 2020-11-12
First Submit QC Date: None
Study First Post Date: 2020-11-16
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-03-22
Results First Submit QC Date: None
Results First Post Date: 2024-04-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-07
Last Update Post Date: 2024-10-09
Last Update Post Date Type: ACTUAL